Besides GRB2 coupled RAS-MAPK and PI3K-AKT signal pathways, BCR-ABL also contributes to unregulated activation of several other signal molecules, such as STAT5 and CRKL, which synergistically participate in the pathogenesis of CML. Here, GRB2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.